Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 70 (1-2), 115-121
- https://doi.org/10.1016/0021-9150(88)90105-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemiaAtherosclerosis, 1985
- Effects of Acipimox, a Nicotinic Acid Derivative, on Lipolysis in Human Adipose Tissue and on Cholesterol Synthesis in Human Jejunal MucosaClinical Science, 1985
- Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, anew inhibitor of lipolysisAtherosclerosis, 1981
- Effects of nicotinic acid therapy on high-density ldpoprotein metabolism in type II and type IV hyperlipoproteinaemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A MetabolismJCI Insight, 1979
- On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemiasAtherosclerosis, 1977
- Element Analysis-The Anatomy of Multiple RegressionJournal of the Royal Statistical Society: Series D (The Statistician), 1969
- A comparison of heritable abnormal lipoprotein patterns as defined by two different techniquesJCI Insight, 1968
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955